Mamta Soni: The Role of Anti-Xa Monitoring in Anticoagulation Management
Mamta Soni, Chief of Laboratory Services at Apollo Health and Lifestyle Limited, shared on LinkedIn:
“Happy to have shared my experience at the well-organized CME program, ‘Anti-Xa Monitoring in Anticoagulation: Bridging Laboratory Insights and Clinical Practice,’ held in Chennai.
The Anti-Xa assay is a functional test that measures the anticoagulant activity of heparin. It is a valuable tool for monitoring heparin therapy, providing a direct and more accurate assessment of its anticoagulant effect, thereby enabling safer and more effective anticoagulation management.
Some key takeaways from my presentation:
- In special clinical settings such as pregnancy, obesity, and renal impairment, Anti-Xa monitoring helps avoid under- or over-anticoagulation, thereby reducing the risk of both bleeding and thrombotic complications .
- It is important to recognize the potential challenges related to assay accuracy, appropriate timing of sample collection, and the influence of individual patient characteristics on test interpretation.
The CME was a scientific treat, bringing together clinical haematologists, paediatricians, and laboratory professionals for insightful discussions and knowledge sharing.
My sincere thanks to Werfen for the opportunity to share my insights and engage with fellow healthcare professionals.”
Stay updated with Hemostasis Today.
-
Sep 23, 2026, 16:04Monia Ezzalfani: Advancing Patient-Centered Care in Hemophilia A and B
-
Sep 23, 2026, 15:49Bilge Başak: How Activated PRP Modulates Osteoarthritic Chondrocyte Function
-
Sep 23, 2026, 14:50Mbonjo Bitsie Dora: Strengthening Sickle Cell Care Through Education, Awareness and Innovation
-
Sep 23, 2026, 13:58The New B12 Diagnostic Algorithm: From Serum Cobalamin to Functional Deficiency
-
Sep 23, 2026, 13:56Noha Soror: Preparing for Hematology and Medical Oncology Board Certification
-
Sep 23, 2026, 13:46Ugochi Ogu: What Can Platelet Proteomics Reveal about Pain and Neurocognitive Vulnerability in Sickle Cell Disease?
-
Sep 23, 2026, 13:42Melissa Hollo: Connecting Obesity and Anemia for Earlier Maternal Risk Intervention
-
Sep 23, 2026, 13:16Beverley Hunt: Advances in Haemostatic Management of Postpartum Haemorrhage
-
Sep 23, 2026, 13:13Ioanna Mela: Recruiting a Research Associate on DNA nanotechnology